Our Antibody Screening Service provides a fast, reliable, and comprehensive solution for identifying high-affinity antibodies from diverse sources, including mouse and rabbit single B cell monoclonal antibodies, as well as advanced nanobody libraries. By leveraging state-of-the-art technologies such as phage display, flow cytometry, and recombinant expression, we ensure the accurate selection of candidates with exceptional specificity and functionality. The service delivers validated sequences, recombinant antibodies, and detailed reports, facilitating seamless downstream applications in research and therapeutic development.
| Service Category | Service Name | Turnaround Time | Workflow | Deliverables with Electronic Report |
| Single B Cell Screening | Mouse Single B Cell Monoclonal Antibody Screening | 8–10 weeks | Antigen preparation → Mouse/rabbit immunization → B cell enrichment → FACS sorting of positive clones → Antibody gene cloning → Recombinant antibody expression → Antibody functional validation → QC & shipment | 2–5 antibody sequences, 1 recombinant antibody clone |
| Rabbit Single B Cell Monoclonal Antibody Screening | ||||
| Natural/Immune Nanobody Library Screening | Human scFv/Fab Library Screening | 2 weeks | Client-provided antigen or in-house antigen → Antigen coating → Antibody screening → Positive clone sequencing → Sequence delivery | Nanobody sequences, protein, project report, recombinant antibody (optional) |
| Camel VHH Library Screening | ||||
| Camel/Alpaca Immune Library Construction & Screening | 8–10 weeks | Client-provided antigen → Camel/Alpaca immunization → PBMC → Phage library construction → Antibody sreening → Positive clone sequencing → Sequence delivery → Recombinant antibody expression & validation → QC & shipment | PBMC, nanobody library, nanobody sequences |
Our Antibody Screening Service covers monoclonal antibodies from single B cells (mouse and rabbit), as well as nanobodies from natural human or camelid libraries. Clients receive validated sequences and, where applicable, recombinant antibody proteins suitable for downstream research or therapeutic applications.
Stay updated with the latest industry news and expert insights.
Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!
